Application based on results from TRANSCEND CLL 004, the first pivotal multicenter trial to show clinical benefit with a CAR T cell therapy in heavily pre-treated patients with relapsed or refractory CLL or SLL, in which
Media invited for unveiling on September 15th @ 4pm in Jupiter, Florida
Safety Shot lowers blood alcohol content by up to 50% in just 30 minutes
JUPITER, Fla., Aug. 17, 2023 (GLOBE NEWSWIRE)